TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cann Group ( (AU:CAN) ) has shared an update.
Cann Group Limited has issued over 15 million fully paid ordinary shares to an Australian private credit fund to fulfill a capitalized interest payment, as previously outlined in their quarterly report. This move, approved by shareholders earlier in the year, signifies the company’s ongoing efforts to manage its financial obligations and maintain transparency with stakeholders, reflecting its commitment to regulatory compliance and strategic financial management.
The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.
More about Cann Group
Cann Group Limited operates in the medical cannabis industry, focusing on the cultivation and production of medicinal cannabis products. The company is engaged in the development and commercialization of cannabis-based therapies, targeting both domestic and international markets.
YTD Price Performance: -71.79%
Average Trading Volume: 4,181,369
Technical Sentiment Signal: Sell
Current Market Cap: A$8.66M
See more insights into CAN stock on TipRanks’ Stock Analysis page.